Eguchi Atsuko, Inomata Takenori, Nakamura Masahiro, Nagino Ken, Iwagami Masao, Sung Jaemyoung, Midorikawa-Inomata Akie, Okumura Yuichi, Fujio Kenta, Fujimoto Keiichi, Miura Maria, Akasaki Yasutsugu, Shokirova Hurramhon, Hirosawa Kunihiko, Kuwahara Mizu, Zhu Jun, Dana Reza, Murakami Akira, Kobayashi Hiroyuki
Department of Hospital Administration, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Ophthalmology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo, 113-0033, Japan.
Jpn J Ophthalmol. 2021 Mar;65(2):271-281. doi: 10.1007/s10384-020-00798-1. Epub 2021 Jan 7.
To determine eye drop type and usage frequency and investigate risk factors for no eye drop use in individuals with symptomatic dry eye (DE) in Japan.
Crowdsourced observational study.
This study was conducted using the DryEyeRhythm smartphone application between November 2016 and September 2019. Data collected included the type and frequency of eye drop use, demographics, medical history, lifestyle, and self-reported symptoms. Symptomatic DE was defined as an Ocular Surface Disease Index total score of ≥ 13. Risk factors for no eye drop use were identified using multivariate logistic regression analyses.
Among 2619 individuals with symptomatic DE, 1876 did not use eye drops. The most common eye drop type was artificial tears (53.4%), followed by hyaluronic acid 0.1% (33.1%) and diquafosol sodium 3% (18.7%). Risk factors (odds ratio [95% confidence interval]) for no eye drop use were age (0.97 [0.97-0.98]), body mass index (1.04 [1.01-1.07]), brain disease (0.38 [0.15-0.98]), collagen disease (0.30 [0.13-0.68]), mental illness other than depression and schizophrenia (0.65 [0.45-0.93]), cataract surgery (0.12 [0.02-0.59]), ophthalmic surgery other than cataract and laser-assisted in situ keratomileusis (0.55 [0.34-0.88]), current (0.47 [0.38-0.57]) or past (0.58 [0.43-0.77]) contact lens use, >8 h screen exposure time (1.38 [1.05-1.81]), <6 h (1.24 [1.01-1.52]) and >9 h (1.34 [1.04-1.72]) sleep time, and water intake (0.97 [0.94-0.98]).
Many participants with symptomatic DE did not use optimized eye drop treatment and identified risk factors for no eye drop use. The DryEyeRhythm application may help improve DE treatment.
确定日本有症状性干眼症(DE)患者的滴眼液类型和使用频率,并调查未使用滴眼液的危险因素。
众包观察性研究。
本研究于2016年11月至2019年9月期间使用DryEyeRhythm智能手机应用程序进行。收集的数据包括滴眼液的使用类型和频率、人口统计学信息、病史、生活方式和自我报告的症状。有症状性DE定义为眼表疾病指数总分≥13分。使用多因素逻辑回归分析确定未使用滴眼液的危险因素。
在2619例有症状性DE患者中,1876例未使用滴眼液。最常见的滴眼液类型是人工泪液(53.4%),其次是0.1%透明质酸(33.1%)和3%地夸磷索钠(18.7%)。未使用滴眼液的危险因素(比值比[95%置信区间])包括年龄(0.97[0.97 - 0.98])、体重指数(1.04[1.01 - 1.07])、脑部疾病(0.38[0.15 - 0.98])、胶原病(0.30[0.13 - 0.68])、除抑郁症和精神分裂症外的精神疾病(0.65[0.45 - 0.93])、白内障手术(0.12[0.02 - 0.59])、除白内障和准分子原位角膜磨镶术外的眼科手术(0.55[0.34 - 0.88])、当前(0.47[0.38 - 0.57])或过去(0.58[0.43 - 0.77])佩戴隐形眼镜、屏幕暴露时间>8小时(1.38[1.05 - 1.81])、睡眠时间<6小时(1.24[1.01 - 1.52])和>9小时(1.34[1.04 - 1.72])以及水分摄入(0.97[0.94 - 0.98])。
许多有症状性DE的参与者未接受优化的滴眼液治疗,并确定了未使用滴眼液的危险因素。DryEyeRhythm应用程序可能有助于改善DE的治疗。